• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

再次回顾整块膀胱肿瘤切除术(ERBT):12 年后重新引入,好得不容忽视。

En bloc resection of bladder tumors (ERBT) revisited 12 years after reintroduction: too good to be further ignored.

机构信息

Department of Urology, Spital Thurgau AG, Kantonsspital Frauenfeld, Pfaffenholzstrasse 4, CH 8501, Frauenfeld, Switzerland.

Division of Urology, Department of Surgical Sciences, Stellenbosch University, Western Cape, South Africa.

出版信息

World J Urol. 2023 Oct;41(10):2577-2582. doi: 10.1007/s00345-023-04629-z.

DOI:10.1007/s00345-023-04629-z
PMID:37819587
Abstract

En bloc resection of bladder tumors (ERBT) orginally described in 1980 and adopted by few centers in the late 1990s has regained attention in the 2010s as a renaissance of a technique with high potential. The advent of new lasers indirectly lead to a better understanding of anatomical dissection from the experience in anatomical dissection in endoscopic enucleation of the prostate. 12 years after the reintroduction of ERBT evidence mounts that it is not only equivalent but better in some regards. However, ERBT still falls short with regard to wide adoption despite the striking technique inherent and reproducible features of accurate staging and specimen quality as requested by pathologist, as well and despite the high intraoperative safety and fast adoption of this technique even in early phase of training. The editorial walks the reader through the timeline of the renaissance speculating why there is a blockage between cognitive understanding and dissonance in surgical practice. The special issues presents the meta-analysis of surgical and oncological data on one hand and the level of understanding and power of this surgical technique in fields offsite oncological results in training achieving results almost right from the start after adoptation. Unlike in earlier years reviewing the literature of ERBT in 2023, ERBT seems not only to be a viable alternative, but something one should turn towards no to underperform with regards to the endpoints achievable by ERBT in a critical disease like bladder cancer.

摘要

整块膀胱肿瘤切除术(ERBT)最初于 1980 年描述,并于 20 世纪 90 年代末被少数中心采用,在 21 世纪 10 年代作为一种具有高潜力的技术复兴重新受到关注。新激光的出现间接导致了对解剖分离的更好理解,这是从前列腺内镜剜除术的解剖分离经验中获得的。在 ERBT 重新引入 12 年后,有证据表明,它不仅在某些方面是等效的,而且更好。然而,尽管 ERBT 具有内在的显著技术特点和可重现的准确分期和标本质量特征,符合病理学家的要求,并且尽管该技术具有术中安全性高且易于在培训早期采用,但它的广泛应用仍存在不足。该社论引导读者了解复兴的时间线,并推测为什么在认知理解和手术实践之间存在障碍。特刊一方面呈现了手术和肿瘤学数据的荟萃分析,另一方面也呈现了对该手术技术的理解水平和力量,以及在培训中远离肿瘤学结果领域的应用效果,在采用后几乎立即取得了成果。与 2023 年回顾 ERBT 文献的早期不同,ERBT 似乎不仅是一种可行的替代方案,而且对于膀胱癌等严重疾病,ERBT 所能达到的终点,人们应该转而采用这种方法,而不是表现不佳。

相似文献

1
En bloc resection of bladder tumors (ERBT) revisited 12 years after reintroduction: too good to be further ignored.再次回顾整块膀胱肿瘤切除术(ERBT):12 年后重新引入,好得不容忽视。
World J Urol. 2023 Oct;41(10):2577-2582. doi: 10.1007/s00345-023-04629-z.
2
A 10-year renaissance of en bloc resection of bladder tumors (ERBT): Are we approaching the peak or is it back to the trough?膀胱肿瘤整块切除术(ERBT)的十年复兴:我们是在接近峰值还是回到低谷?
World J Urol. 2023 Oct;41(10):2607-2615. doi: 10.1007/s00345-023-04439-3. Epub 2023 May 27.
3
En bloc resection of bladder tumors: challenges and unmet needs in 2022.整块切除膀胱肿瘤:2022 年的挑战和未满足的需求。
Future Oncol. 2022 Jun;18(20):2545-2558. doi: 10.2217/fon-2021-1228. Epub 2022 Jun 1.
4
En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor.膀胱尿路上皮癌整块切除术(EBRUC):一项欧洲多中心研究,比较激光和电切整块经尿道膀胱肿瘤切除术的安全性、有效性和结果。
World J Urol. 2015 Dec;33(12):1937-43. doi: 10.1007/s00345-015-1568-6. Epub 2015 Apr 25.
5
En Bloc Versus Conventional Transurethral Resection of Bladder Tumors: A Single-center Prospective Randomized Noninferiority Trial.整块切除与传统经尿道膀胱肿瘤切除术治疗膀胱肿瘤的单中心前瞻性随机非劣效性试验。
Eur Urol Oncol. 2022 Aug;5(4):440-448. doi: 10.1016/j.euo.2022.05.001. Epub 2022 May 23.
6
An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting.国际协作共识声明:整块切除膀胱肿瘤,包含两项系统评价、两轮德尔菲调查和一次共识会议。
Eur Urol. 2020 Oct;78(4):546-569. doi: 10.1016/j.eururo.2020.04.059. Epub 2020 May 8.
7
En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature.整块切除术治疗非肌肉浸润性膀胱癌:文献复习。
Curr Opin Urol. 2020 Jan;30(1):41-47. doi: 10.1097/MOU.0000000000000697.
8
Safety, feasibility, and quality of thulium laser en-bloc resection for treatment of non-muscle invasive bladder cancer.钬激光整块切除术治疗非肌层浸润性膀胱癌的安全性、可行性和质量。
Int Urol Nephrol. 2023 Dec;55(12):3103-3109. doi: 10.1007/s11255-023-03752-5. Epub 2023 Aug 28.
9
Current Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder Cancer.经尿道整块切除非肌层浸润性膀胱癌的当前证据。
Eur Urol Focus. 2017 Dec;3(6):567-576. doi: 10.1016/j.euf.2016.12.004. Epub 2017 Jan 11.
10
En bloc resection, is this the future of non-muscle invasive bladder cancer management? Presentation of our technique and brief review of the literature.整块切除,这会是非肌层浸润性膀胱癌治疗的未来方向吗?介绍我们的技术并对文献进行简要回顾。
Urologia. 2023 Feb;90(1):75-79. doi: 10.1177/03915603221093739. Epub 2022 Apr 25.

本文引用的文献

1
A Territory-wide Study Investigating the Dose and Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with Intermediate- and High-risk Non-muscle-invasive Bladder Cancer.一项全港性研究调查不同卡介苗菌株在中高危非肌肉浸润性膀胱癌患者中的剂量和疗效。
Eur Urol Oncol. 2024 Jun;7(3):438-446. doi: 10.1016/j.euo.2023.09.014. Epub 2023 Oct 11.
2
Results from a global multicenter registry of 6193 patients to refine endoscopic anatomical enucleation of the prostate (REAP) by evaluating trends and outcomes and nuances of prostate enucleation in a real-world setting.一项全球多中心注册研究纳入了 6193 例患者,旨在通过评估真实世界中前列腺解剖性剜除术(REAP)的趋势、结局和细微差别,对其进行优化。
World J Urol. 2023 Nov;41(11):3033-3040. doi: 10.1007/s00345-023-04626-2. Epub 2023 Oct 2.
3
Cognitive Bias and Dissonance in Surgical Practice: A Narrative Review.手术实践中的认知偏差与失调:叙事性综述
Surg Clin North Am. 2023 Apr;103(2):271-285. doi: 10.1016/j.suc.2022.11.003.
4
Case-based review of dietary management of cystinuria.胱氨酸尿症饮食管理的病例回顾
World J Urol. 2023 May;41(5):1215-1220. doi: 10.1007/s00345-022-04263-1. Epub 2022 Dec 24.
5
Grade group 1 prostate cancer on biopsy: are we still missing aggressive disease in the era of image-directed therapy?活检中的 1 级前列腺癌:在影像引导治疗时代,我们是否仍遗漏侵袭性疾病?
World J Urol. 2022 Oct;40(10):2423-2429. doi: 10.1007/s00345-022-04130-z. Epub 2022 Aug 18.
6
The DEpth of Endoscopic Perforation scale to assess intraoperative perforations during transurethral resection of bladder tumor: subgroup analysis of a randomized controlled trial.深度内镜穿孔评分评估经尿道膀胱肿瘤切除术术中穿孔:一项随机对照试验的亚组分析。
World J Urol. 2023 Oct;41(10):2583-2589. doi: 10.1007/s00345-022-04052-w. Epub 2022 Jun 4.
7
Surgeon's heuristics and decision making: a BPH storytelling.外科医生的启发式方法与决策:一个前列腺增生的故事
World J Urol. 2021 Jul;39(7):2407-2408. doi: 10.1007/s00345-020-03579-0. Epub 2021 Jan 6.
8
Transurethral en bloc submucosal hydrodissection vs conventional resection for resection of non-muscle-invasive bladder cancer (HYBRIDBLUE): a randomised, multicentre trial.经尿道整块黏膜下注水分离术与传统切除术治疗非肌层浸润性膀胱癌的比较(HYBRIDBLUE):一项随机、多中心试验
BJU Int. 2020 Oct;126(4):509-519. doi: 10.1111/bju.15150. Epub 2020 Aug 10.
9
An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting.国际协作共识声明:整块切除膀胱肿瘤,包含两项系统评价、两轮德尔菲调查和一次共识会议。
Eur Urol. 2020 Oct;78(4):546-569. doi: 10.1016/j.eururo.2020.04.059. Epub 2020 May 8.
10
A Systematic Review and Meta-analysis of Delay in Radical Cystectomy and the Effect on Survival in Bladder Cancer Patients.膀胱癌患者根治性膀胱切除术延迟与生存影响的系统评价和荟萃分析。
Eur Urol Oncol. 2020 Apr;3(2):239-249. doi: 10.1016/j.euo.2019.09.008. Epub 2019 Oct 23.